- Part 19: For the preceding part double click ID:nRSH4027Rr
changes at the state and federal levels aimed at imposing price controls
on medicines and increasing price transparency. For more information,
please see Regulatory requirements and Pricing of medicines in the
Marketplace section from page 13 and page 14, respectively.In the EU,
efforts by the EC to reduce inconsistencies and improve standards in the
disparate national pricing and reimbursement systems met with little
immediate success as Member States guard their right to make healthcare
budget decisions. The industry continues to be exposed in Europe to
various ad hoc cost-containment measures and reference pricing
mechanisms, which impact prices. There is a trend towards increasing
transparency and comparison of prices among EU Member States. Recent
controversy regarding the high price of a drug marketed by one of our
- More to follow, for following part double click ID:nRSH4027Rt